Elucidating Complex Biology in the Immuno-Oncology Era
The Universal Cancer Immunogenomics Platform
A Single Platform. A Single Sample. Multiple Biomarkers.
Predictive & Prognostic
ImmunoID NeXT provides a multidimensional view of the tumor and the TME, empowering our partners to extract the most information from the least amount of sample.
Ready to streamline your precision oncology translational and clinical research programs?
- AACR Tumor Immunology and Immunotherapy Conference USA, Boston, MA | November 17-20
- NeoAG Summit USA, Boston, MA | November 21-22
- ESMO Immuno-Oncology Congress, Geneva, Switzerland | December 11-14